Keragon, an AI-powered healthcare automation platform, secured a $7.5M seed round six months post-launch, bringing its total funding to $10.5M

NEW YORK, Feb. 12, 2025 /PRNewswire/ — Keragon, an AI-powered, HIPAA-compliant automation platform for healthcare, has raised $7.5 million in an oversubscribed seed funding round led by Upfront Ventures, with early investors Afore Capital, Focal, and 25m Health doubling down. This brings Keragon’s total funding to $10.5 million. Six months since product launch, the company has already surpassed 100 paying customers, is growing at a 30% month-over-month rate, and has successfully executed more than 2 million workflow automations.

“Healthcare providers, front and back office staff are weighed down by a long tail of point solutions that don’t talk to each other and slow down patient care. Keragon turns this fragmentation into a connected ecosystem, and is already beloved by numerous clinics saving hours of manual work,” said Kevin Zhang, Partner at Upfront Ventures.

Keragon enables healthcare professionals to seamlessly integrate over 300 popular software tools — including electronic health records (EHRs) like athenahealth, Healthie, Elation Health and Canvas Medical, scheduling platforms, referral management systems, AI medical scribes etc – without any engineering required. This streamlines real-time data exchange, reduces administrative burdens, and safeguards patient data. Recently, Women’s Mental Health Specialists, a clinic serving over 1,000 patients, has cut 5 hours of administrative work per week using Keragon, enabling faster referrals while increasing revenue by 15%. Other common use cases include:

  • Patient intake and appointment scheduling
  • Patient marketing and communication
  • Internal notifications and team coordination

“With Keragon behind the scenes, we’ve been able to improve our processes and expand our operations. Plus, their support is next-level. In a nutshell, Keragon is like Zapier for healthcare, but HIPAA-compliant and way faster,” said Kevin Bundy, CEO of Alive IV and Wellness, a Keragon customer.

Looking ahead, Keragon is doubling down on AI-powered automation. “Integrations are Keragon’s backbone. Connecting complex systems at scale and bringing all the tools our customers use into one unified & compliant ecosystem is our top priority,” said Conno Christou, CEO & Co-founder of Keragon. “With the comprehensive best practices gleaned across these tried and true workflow automations, we are now adding an agentic AI layer to guide and personalize any existing and new automation to each healthcare professional and organization.”

About Keragon
Keragon is an AI-powered healthcare automation platform that enables healthcare professionals to easily connect 300+ popular software and build powerful automations  in a HIPAA-compliant way — no coding required! Learn more at  https://keragon.com

Contact: press@keragonhq.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/keragon-an-ai-powered-healthcare-automation-platform-secured-a-7-5m-seed-round-six-months-post-launch-bringing-its-total-funding-to-10-5m-302374845.html

SOURCE Keragon

Staff

Recent Posts

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

23 minutes ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

14 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

17 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

17 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

17 hours ago